| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/11/2009 | CN100467484C SARS early diagnostic method and reagent box |
| 03/11/2009 | CN100467483C Peptide derived from a VCA-p18 capside antigen of the epstein-barr virus and the use thereof |
| 03/10/2009 | US7501565 Plants and seeds of hybrid corn variety CH428066 |
| 03/10/2009 | US7501559 Plants made insect resistant by transforming their nuclear genome with two or more DNA sequences, each encoding a different non-competitively binding Bacillus thuringiensis protoxin or insecticidal part thereof; gene expression; chimeric genes |
| 03/10/2009 | US7501558 Transgenic plants, such as wheat or corn, comprising cells having specified nucleic acid sequence; seeds and flours; foods, feeds, dough, batters, pastries, cookies, pastries, cookies, pasta, wafers bread or candy; foods tolerable for sufferers of celiac disease and gluten intolerance; food processing |
| 03/10/2009 | US7501553 Non-human transgenic mammal comprising a modified MSP-1 nucleic acid |
| 03/10/2009 | US7501503 Compositions and methods for inhibiting RNase H activity of retroid reverse transcriptase |
| 03/10/2009 | US7501502 Viral vectors with nucleotide sequence operably linked to cytomegalo virus promoter for expression; host cells, genetic engineering; 85P1B3 gene or fragment or its encoded protein which can be used to elicit an immune response; diagnosis |
| 03/10/2009 | US7501501 MHC-Class II restricted melanoma antigens and their use in therapeutic methods |
| 03/10/2009 | US7501500 Inhibiting denaturation of nucleic acid duplexes |
| 03/10/2009 | US7501499 Modified hemoglobin and methods of making same |
| 03/10/2009 | US7501497 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 03/10/2009 | US7501491 recombinant viral genome containing a deletion in the glycoprotein genes; polypeptide is derived from infectious bronchitis virus, Newcastle disease virus, infectious bursal disease virus, and Marek's disease virus; vaccines |
| 03/10/2009 | US7501490 Adiponectin receptor and gene encoding the same |
| 03/10/2009 | US7501489 cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use |
| 03/10/2009 | US7501488 Proteorhodopsin mutants with improved optical characteristics |
| 03/10/2009 | US7501487 Polypeptides that modulate transcription; DNA encoding receptors, expression vectors, cells transformed with such expression vectors; hormone-like proteins; differ from known retinoic acid receptors in protein primary sequence and in responsiveness to various retinoids |
| 03/10/2009 | US7501485 Wound heraling agents; polypeptide |
| 03/10/2009 | US7501484 Methods and DNA constructs for high yield production of polypeptides |
| 03/10/2009 | US7501402 Acidic oligosaccharide fragments produced by marine sponges and sea urchin embryos; potent stimulators of natural killer cells and gamma delta T cells; cancer, viral infections |
| 03/10/2009 | US7501397 Helical peptidomimetics with enhanced activity |
| 03/10/2009 | US7501394 Bacteriophage T7 clone containing a truncated coat p10 and a wild-type tail fiber protein p17 selectively localizes to hepatocytes when injected into a blood vessel in a mammal; T7 p17 protein and drug, component of a drug or polynucleotide complex and polynucleotide |
| 03/10/2009 | US7501286 Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry |
| 03/10/2009 | US7501273 Peptidylarginine deiminase 6 |
| 03/10/2009 | US7501265 Method for producing and cleaving a fusion proteins with an n-terminal chymosin pro-peptide |
| 03/10/2009 | US7501263 Nucleic acids encoding mammalian T-type calcium channels |
| 03/10/2009 | US7501262 Recombinant DNA, gene expression vectors, and transformants capable of expressing a gene without inducing gene expression with an inducer; genetic engineering |
| 03/10/2009 | US7501249 Human cytoplasmic polyadenylation element binding protein and uses thereof |
| 03/10/2009 | US7501239 Method of detecting β3 adrenaline receptor mutant gene and nucleic acid probe and kit therefor |
| 03/10/2009 | US7501234 Stress proteins and uses therefor |
| 03/10/2009 | US7501132 Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| 03/10/2009 | US7501131 Haemophilus influenzae type IV pili |
| 03/10/2009 | US7501130 Methods for treating myofascial pain |
| 03/10/2009 | US7501128 DNA expression vector comprising a portion of a rhabdovirus G protein and further comprising on the same vector a portion of a second protein coding sequence from a pathogenic organism other than said rhabdovirus, with a pharmaceutically acceptable carrier; diseases in fish |
| 03/10/2009 | US7501126 Targeting of herpes simplex virus to specific receptors |
| 03/10/2009 | US7501125 Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
| 03/10/2009 | US7501124 Administering allogenic or xenogeneric cell; complexing with antigen |
| 03/10/2009 | US7501123 Human G-protein chemokine receptor (CCR5) HDGNR10 |
| 03/10/2009 | US7501118 Human gene relating to respiratory diseases and obesity |
| 03/10/2009 | CA2616144A1 Insect olfactory receptors and ligands therefor |
| 03/10/2009 | CA2467959C Production of adeno-associated virus in insect cells |
| 03/10/2009 | CA2329255C Method of producing thy a-strains of vibrio cholerae, such strains and their use |
| 03/10/2009 | CA2301046C 13c, 15n, 2h labeled proteins for nmr structure determinations and their preparation |
| 03/10/2009 | CA2270408C Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use |
| 03/10/2009 | CA2252896C Inactivation resistant factor viii |
| 03/07/2009 | CA2639335A1 Anti-chikungunya monoclonal antibodies and uses thereof |
| 03/07/2009 | CA2598966A1 Anti-chikungunya monoclonal antibodies and uses thereof |
| 03/05/2009 | WO2009029847A1 Compositions and methods of using proislet peptides and analogs thereof |
| 03/05/2009 | WO2009029569A1 Hiv env proteins with modifications in the v3 loop |
| 03/05/2009 | WO2009029342A2 B7-dc variants |
| 03/05/2009 | WO2009029054A1 P53 isoform gene(s) and uses thereof |
| 03/05/2009 | WO2009028973A1 Massive production of mycobacterial glucosyl-3-phosphoglycerate synthase and the use of this enzyme as a target for antimycobacterial substances |
| 03/05/2009 | WO2009028968A1 Cell marker of melanocyte cell lineage and uses thereof |
| 03/05/2009 | WO2009028880A2 Biomarker composition for detecting diabetic retinopathy and diagnostic kit therefor |
| 03/05/2009 | WO2009028662A1 Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin |
| 03/05/2009 | WO2009028625A1 Method of binding protein to support using tamavidin |
| 03/05/2009 | WO2009028531A1 Docrine polypeptide and method of purifying recombinant fused protein using the same |
| 03/05/2009 | WO2009028319A1 Peptide derived from ephb6 mutant capable of binding to hla-a24 or hla-a2 molecule |
| 03/05/2009 | WO2009027752A2 Process for producing hepcidin |
| 03/05/2009 | WO2009027690A1 Diagnostic agent |
| 03/05/2009 | WO2009027688A1 Influenza antigen delivery vectors and constructs |
| 03/05/2009 | WO2009027539A2 Method for producing a transgenic plant cell, a plant or a part thereof with increased resistance to plant disease |
| 03/05/2009 | WO2009027495A1 Method for manufacturing a modified peptide |
| 03/05/2009 | WO2009027471A1 Methods for increasing protein titers |
| 03/05/2009 | WO2009027369A1 Method for selectively modifying a protein |
| 03/05/2009 | WO2009027335A2 Polypeptides, such as lipases, capable of altering the seed storage content in transgenic plants |
| 03/05/2009 | WO2009027313A2 Pathogen control genes and methods of use in plants |
| 03/05/2009 | WO2009027284A1 Purification of osteopontin |
| 03/05/2009 | WO2009027063A2 MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING β1-ADRENOCEPTOR ANTIBODIES |
| 03/05/2009 | WO2009026941A1 Genetically encoded calcium sensors comprising the c-terminal lobe of troponin c and a fluorescence tag |
| 03/05/2009 | WO2009026723A1 Antigenic compositions and use of same in the targeted delivery of nucleic acids |
| 03/05/2009 | WO2009026692A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/05/2009 | WO2009026687A1 Neuroprotection using nap-like and sal-like peptide mimetics |
| 03/05/2009 | WO2009026653A1 Neuroplasticity assay |
| 03/05/2009 | WO2009026622A1 Modulators of hypersensitivity reactions |
| 03/05/2009 | WO2009026615A1 Group a streptococcus pharmaceutical compositions and methods thereof |
| 03/05/2009 | WO2009012384A3 Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1 |
| 03/05/2009 | WO2009012382A3 Compositions, kits, and methods for the modulation of immune responses using galectin-1 |
| 03/05/2009 | WO2009012224A3 Peptide-based regulation of gap junctions |
| 03/05/2009 | WO2009010539A3 Receptor for interleukin-6 (il-6) from macaca fascicularis |
| 03/05/2009 | WO2009010474A9 Antibody or fragment thereof recognizing avitagtm and uses thereof |
| 03/05/2009 | WO2009009399A3 Ixostatins and their use |
| 03/05/2009 | WO2009008756A3 DNA SEQUENCE ENCODING A SPECIFIC L-ARABINOSE TRANSPORTER, A cDNA MOLECULE, A PLASMID COMPRISING THE SAID DNA SEQUENCE, HOST CELL TRANSFORMED WITH SUCH PLASMID AND APPLICATION THEREOF |
| 03/05/2009 | WO2009006732A9 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
| 03/05/2009 | WO2009006323A3 Methods and marker combinations for screening for predisposition to lung cancer |
| 03/05/2009 | WO2008157263A3 Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same |
| 03/05/2009 | WO2008155291A3 Chlamydia antigens |
| 03/05/2009 | WO2008153705A3 Methods of treating, diagnosing and detecting fgf21-associated disorders |
| 03/05/2009 | WO2008142034A3 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production |
| 03/05/2009 | WO2008137881A3 Ehrlichia ewingii proteins, nucleic acids, and methods of their use |
| 03/05/2009 | WO2008133961A3 Igf-1r binding proteins and antagonists |
| 03/05/2009 | WO2008122435A3 Use gene variants of the human meis1, btbd9, map2k5, lbxcor1, ptprd or a2bp1 gene for diagnostic and therapeutic approaches to restless legs syndrome (rls) |
| 03/05/2009 | WO2008112917A3 Peptidyl fluoromethylketones as inhibitors of viral replication |
| 03/05/2009 | WO2008109677A3 Modified enzyme and treatment method |
| 03/05/2009 | WO2008106551A3 Brachyury polypeptides and methods for use |
| 03/05/2009 | WO2008097541A3 Variants derived from actriib and uses therefor |
| 03/05/2009 | WO2008066752A3 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| 03/05/2009 | WO2008063776A3 Antibodies to lymphotoxin-alpha |
| 03/05/2009 | WO2008054713A3 Tissue specific gene therapy treatment |
| 03/05/2009 | WO2007072037A9 Cyclic antimicrobial peptides |